Introduction
Inflammatory bowel disease (IBD) is a chronic recurrent disease of the digestive tract but currently with an unknown etiology. Several mechanisms including synthesis and release of different proinflammatory mediators, reactive oxygen and nitrogen species, eicosanoids, platelet-activating factor, and cytokines have been proposed for IBD [1, 2] . In the recent years, role of microorganisms in the pathogenesis of IBD has found more support [3] [4] [5] [6] [7] .
It has been suggested that control of oxidative stress in IBD may attenuate biochemical and histopathological variables of IBD [8] [9] [10] [11] . In this regard, existence of oxidative stress in biological fluids such as saliva [12] , plasma [13] , and colonic mucosal biopsies [2] of subjects with IBD has been already confirmed.
Nitric oxide (NO) is a free radical produced from L-arginine via the enzyme NO synthase (NOS). NOS is available in both constitutive (eNOS + nNOS) and inducible (iNOS) forms. Both neutrophils and macrophages recruited to the site of inflammation express iNOS and produce a large amount of NO [14, 15] . The overproduction of NO seems to play a role in the pathogenesis of IBD [16] [17] [18] . Among different inflammatory mediators that have been implicated in IBD, tumor necrosis factor-alpha (TNF-α) is prominent. The therapeutic gain of anti TNF-α antibody compounds in Crohn's disease [19] , and also in ulcerative colitis [20] , confirms the vital role of TNF-α in IBD. A new strategy of treatment in IBD is blocking TNF-α by specific compounds like Infliximab.
Compounds with antioxidant activity should therefore be investigated as potential therapeutic agents in IBD. Some agents have already proved effective in experimental conditions, the antioxidants such as vitamin E, selenium, and trimetazinide were found to be beneficial in IBD [21, 22] . Herbal products rich in antioxidants have also shown beneficial effects in IBD [8] [9] [10] . The synthetic thiol compound N-acetylcysteine (NAC) is one of the powerful antioxidants that has been mainly introduced in the treatment of acetaminophen overdosage, but in recent years its positive effects in other disease models have been indicated [23, 24] . NAC is known to act by raising the intracellular concentrations of cysteine and hence reducing the concentration of glutathione (GSH) and/or scavenging radical oxygen species [23] .
Several experimental models of IBD have been introduced and fortunately results of most of them have been extrapolated to humans. Our lab studies have shown reliability of the experimental model of colitis in mouse and rat in terms of both biochemical and pathological changes [8] [9] [10] 11, 25] .
In the present study, we aimed to determine whether NAC could protect the colonic mucosa against an inflammatory attack in a mouse model of IBD induced by oral administration of DSS by examining the nitrosative and oxidative stress biomarkers and measuring TNF-α as the last key element of inflammation in the colon tissue.
Experimental Procedures

Chemicals
Thiobarbituric acid (TBA), 1,1,3,3-tetra ethoxypropan, linoleic acid, trichloroacetic acid (TCA), n-butanol, hexadecyl trimethyl ammonium bromide (HETAB), ethylene diamine tetra acetic acid (EDTA), O-dianisidine hydrochloride, hydrogen peroxide, acetic acid, phosphate buffer, sodium acetate, 2,4,6-tripyridyl-striazine (TPTZ), folin-ciocalteu reagent, FeCl 3 -6H 2 O, sodium sulfate, potassium dihydrogen phosphate (KH 2 PO 4 ), potassium hydrogen diphosphate (K 2 HPO 4 ), peroxide hydrogen (H 2 O 2 ) from Merck (Tehran), NAC from local pharmaceutical company, dextran sodium sulfate (DSS), SOD determination kit from Fluka (Tehran), sulfanilamide (Griess Reagent 1), N-1-napthylenediamine dihydrochloride (NED, Griess Reagent 2) from Promega (USA), and rat specific TNF-α ELISA kit from BioSource (Belgium) were used.
Animals
NMRI albino mice, weighing between 20 and 30 g were used. Animals were maintained under standard conditions of temperature (23±1ºC), relative humidity (55±10%), and 12/12 hours light/dark cycle, and fed with a standard pellet diet and water ad libitum. They were housed in standard polypropylene cages with a wire mesh top. All ethical themes of the studies on animals were considered carefully and the experimental protocol was approved by the Ethic Committee of PSRC/TUMS.
Induction of colitis and treatments
The study comprised five different groups with six mice in each group. All animals except the normal group received 0.1 mL of 3% DSS solution for 7 days [26, 27] . At the forth day, they were separated into 4 groups as follow: control animals that received no treatment; NAC-treated animals that were administered with NAC (106, 160, and 240 mg/kg) for 4 days [24] in 3 separate groups. At the end of treatment period (7 days), mice were anaesthetized using pentobarbital sodium (55 mg/ kg, i.p.) and then the abdomen was dissected open and the colon was removed. A long piece of colon (5 cm) was flushed gently with saline, cut open and maintained at -20ºC. To measure biochemical biomarkers, the colonic samples were minced on ice and homogenized in 10 mL of ice cold 50 mM potassium phosphate buffer (pH 6.0), containing 0.5% HETAB and 10 mM EDTA [8] [9] [10] [11] . The homogenates were then sonicated and centrifuged for 20 min at 12000 g and the supernatant was transformed into several microtubes for separate biochemical assays and frozen at -20ºC until analysis.
Total antioxidant power (TAP) of colon homogenate
TAP of the colon homogenate was determined by measuring the ability of colon to reduce Fe 3+ to Fe 2+ . The complex between Fe 2+ and TPTZ gives a blue color with a maximum absorbance at 593 nm [28] .
Total thiol molecules (TTM) of colon homogenate
TTM of the colon homogenate was measured spectrophotometrically at 412 nm using the DTNB reagent as described previously [29] .
Lipid peroxides (LP) of the colon homogenate
In this method, LP is determined on the basis of TBA reactive substances (TBARS). Colon homogenate was mixed with TCA (20%) and the precipitate was dispersed in H 2 SO 4 (0.05 M). TBA (0.2% in 2 M sodium sulfate) was added and the mixture was heated for 30 min in boiling water bath. LP adducts were extracted by n-butanol and the absorbance was measured at 532 nm [30] .
Catalase (CAT) activity of colon homogenate
CAT activity was measured at 20°C by monitoring the decomposition of hydrogen peroxide as described by Aebi [31] . The reaction mixture consisted of 1.5 ml of the colon homogenate in potassium phosphate buffer (50 mM, pH 7.0), and 0.5 ml of hydrogen peroxide solution (10 mM). The absorbance was recorded for 2 minutes at 240 nm immediately after adding hydrogen peroxide solution. CAT activity was expressed as moles of hydrogen peroxide reduced/min/mg protein.
Superoxide dismutase (SOD) activity of colon homogenate
Superoxide dismutase (SOD) catalyzes the dismutation of the superoxide anion (O2-) into hydrogen peroxide and molecular oxygen [32] . SOD assay was done by utilizing a highly water-soluble tetrazolium salt, WST-1 (2-(4-lodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt) that produces a water-soluble formazan dye upon reduction with a superoxide anion. The rate of reduction with O2 is linearly related to the xanthine oxidase (XO) activity, and is inhibited by SOD. The IC50 (50% inhibition activity of SOD or SOD-like materials) is determined by measuring the absorbance in 450 nm by a spectrophotometer.
Tumor necrosis factor-α (TNF-α) of colon homogenate
The Invitrogen Mice Tumor Necrosis Factor-α kit is a solid phase sandwich enzyme linked immuno-sorbent assay (ELISA) system. An antibody specific for TNF-α has been coated onto the wells of the microtiter strips provided. During the first incubation, the TNF-α antigen binds simultaneously to the immobilized (capture) antibody on one site, and to the solution phase biotinylated antibody on a second site. After removal of excess second antibody streptavidin-peroxidase (enzyme) is added. After a second incubation and washing to remove all unbound enzymes, a substrate solution is added, which is acted upon by the bound enzyme to produce color. The intensity of this colored product is directly proportional to the concentration of TNF-α present in the original specimen [33] .
Nitric oxide (NO) of colon homogenate
Griess Reagent System is based on measuring total nitrite [34] in the presence of sulfanilamide and n-1-naphylethylenediamine dihydrochloride (NED). The detection sensitivity is a maximum of 2.5 mM (125 pmol) nitrite.
Total protein of colon homogenate
The concentration of protein in the colon homogenate was determined by the Lowry procedure using bovine serum albumin as the standard [35] .
Statistical analysis
Values are reported as mean±SE. To ensure the variances of data are distributed properly and also to ensure significant changes among multiple groups including normal, control and three separate NACtreated, the Tukey multiple comparison post-hoc was done following ANOVA. Tukey test data was considered significant if P values were < 0.01.
Results
Effects of NAC on colon TAP
Data are shown in Figure 1 . 
Effects of NAC on colon LP
Data are shown in Figure 2 . There was a significant (P<0.01) elevation in TBARS in IBD mice as compared with the normal mice. Administration of NAC (160 and 240 mg/kg/day) significantly (P<0.01) decreased LP in colon of IBD mice and reached near to normal values.
Effects of NAC on colon TTM
As shown in Figure 3 , there was a significant (P<0.01) increase in TTM of IBD mice treated with doses of 160 and 240 mg/kg of NAC in comparison with the IBD control mice. NAC reached normal range values. 
Effects of NAC on colon NO
As shown in Figure 5 , there was a significant (P<0.01) elevation in NO of IBD mice as compared with the normal animals. Administration of NAC (160 and 240 mg/kg/ day) significantly (P<0.01) decreased NO as compared with control group and reached near to normal values.
Effects of NAC on colon SOD and CAT
Data are shown in Figures 6 and 7 . Induction of colitis in control animals significant (P<0.01) reduced the activities of SOD and CAT as compared with normal mice. Administration of NAC (160 and 240 mg/kg/ day) significantly (P<0.01) improved SOD and CAT as compared with the IBD control group.
Discussion
The present results indicate that NAC has adequate potential for protection against DSS-induced colitis in mice by ameliorating key biomarkers of colonic inflammation, i.e. oxidative and nitrosative stress of colonic damage, SOD and CAT activities, and colon TNF-α concentration. To ensure the variances of data are distributed properly, and also to ensure changes among multiple groups including normal, control and three separate NAC-treated groups are significant, the Tukey post-hoc multiple comparison test was done following ANOVA.
It is thought that NAC enhances the synthesis of GSH, primarily under conditions when the demand for GSH is increased, such as during excessive oxidative stress, or during certain disease processes. Most of the beneficial effects of NAC are suggested as being a result of its ability to either reduce extracellular cystine to cysteine, or to be a source of thiol (SH) metabolites. As a source of SH groups, NAC stimulates glutathione synthesis, enhances glutathione-S-transferase activity, and acts on reactive oxidant radicals. NAC was also found as a powerful scavenger of hypochlorous acid (HOCL). HOCL, produced by the action of myeloperoxodase on hydrogen peroxide in the presence of chloride ions, is importantly involved in the inflammatory reaction in colitis and its scavenging potential accounts for observed protective effect of NAC [22, 36] .
Oxidative stress is believed to play a key role in the pathogenesis of intestinal damage in IBD. As a matter of fact, intestinal mucosal damage in IBD, including Crohn's disease and ulcerative colitis, is related to increased free radical production and to a low concentration of endogenous antioxidant defense [4, 37] .
There are supporting evidences on the ability of NAC to decrease LP levels in studies in which experimental damage was formed other than colitis [38, 39] . Levels of LP, antioxidant enzymes, and TAP are known markers of oxidative stress in experimental models of IBD [40] .
TTM exist in compounds like cysteine, methionine, and glutathione in the body with multiple regulatory and protective roles. They are involved in defense against chemically-induced cell and tissue injuries. Non-protein thiols usually scavenge free radicals and protein thiols affect enzyme activity, cell viability and membrane stability. The protective role of thiol compounds, especially GSH, was documented in the stomach and liver [41] . In the colon, thiol blockers, like iodoeactamide or N-ethylmaleimide, are used for the induction of inflammation [42] . The SOD and CAT are the two other components of enzymatic antioxidant system. SOD is a candidate drug for modulating the pathogenic factor of oxidative stress. It has been shown that dosedependent treatment with SOD inhibits peroxidation of lipids in the inflamed intestine [43] . Present study indicated that reduced levels of SOD and CAT in animals with colitis improved following NAC treatment.
Of course, there are controversial data on the status of CAT in IBD experimental models. For example, activity of CAT has been reported to be unchanged after acetic acid-induced colitis [44] . Regarding SOD, the existing reports support increased level of SOD in acetic acid model of colitis [44] [45] [46] and also in TNBS plus ethanolinduced colitis [47] . Decreased or increased activities of SOD and CAT both indicate an imbalance between oxidants and antioxidants within the tissue. In most cases of acute exposure to oxidants, SOD and CAT are activated to some extent against oxidants. But if they cannot compensate antioxidants necessary to cope with oxidants, then oxidants would be able to damage cells and finally would deplete the body antioxidant burden. The later most usually occurs in chronic exposures and also if the oxidants are very strong.
Regarding occurrence of oxidative stress as mentioned above, it is not surprising to see that increased level of NO in DSS-induced colitis animals is prevented by NAC. There is evidence that NAC decreases concentration of NO through inhibition of inducible NO synthase (iNOS) [48] . The overexpression of iNOS and the subsequent increased generation of NO have been demonstrated in colon biopsies of patients with ulcerative colitis [49] that found to be in relation with disease severity [13, 50] . Also, it has been reported that whereas the long-term (7 days) NAC treatment prevents NO accumulation, NO concentration increases with short term (2 days) NAC therapy [51] .
The current view of the cytokine network in IBD supports the notion that TNF-α activates a cytokine cascade characterized by the simultaneous production of pro-inflammatory cytokines, such as interleukin (IL)-1, IL-6, several chemokines, GM-CSF, and of anti-inflammatory factors, such as IL-10, IL-1 receptor antagonist, and soluble TNF receptor [52] . NAC, by decreasing TNF-α, is suggested to possess an inhibitory [14, 15] . Taking all data collectively, it is concluded that NAC improves the management of mouse model of IBD. Regarding the adverse effects that commonly seen in patients receiving regular drugs like salazines, antibiotics, or anti TNF-α, NAC may easily be substituted because it has lower incidence of adverse effects. Clinical trials are needed to elucidate the efficacy of NAC in the management of IBD patients.
